Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease (Q38706110)

5 September 2017

title

Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease (English)

1 reference

5 September 2017

main subject

cerebrovascular disease

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Paolo Spallarossa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Enrico Adriano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

21 January 2016

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1955-1967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia.

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Searching for a therapy of creatine transporter deficiency: some effects of creatine ethyl ester in brain slices in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine monohydrate supplementation for 10 weeks mediates neuroprotection and improves learning/memory following neonatal hypoxia ischemia encephalopathy in female albino mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Exocytotic release of creatine in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Functions and effects of creatine in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Cyclocreatine phosphate, an analogue of creatine phosphate, does not improve hypoxic tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Pathophysiology of anoxic depolarization: new findings and a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Chlorpromazine protects brain tissue in hypoxia by delaying spreading depression-mediated calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Neuroprotective effects of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Mitochondria and ALS: implications from novel genes and pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine protects against excitoxicity in an in vitro model of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Role of creatine phosphate as a myoprotective agent during coronary artery bypass graft in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine and creatine analogues in hypertension and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effects of Chronic Dietary Creatine Feeding on Cardiac Energy Metabolism and on Creatine Content in Heart, Skeletal Muscle, Brain, Liver and Kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Structural organization of astrocytes in the rat hippocampus in the post-ischemic period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Evidence for a relation between creatine phosphate level and polarity of the cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Intracerebroventricular administration of creatine protects against damage by global cerebral ischemia in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Reduced ATP concentration as a basis for synaptic transmission failure during hypoxia in thein vitroguinea-pig hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Extracellular creatine regulates creatine transport in rat and human muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine and cyclocreatine attenuate MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The role of creatine kinase in inhibition of mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The neuroprotective effect of creatine in rats with cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The response of isolated cardiac muscle to acute anoxia: protective effect of adenosine triphosphate and creatine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Kinetics of creatine in blood and brain after intraperitoneal injection in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Protective effects of some creatine derivatives in brain tissue anoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

In vivo neuroprotection by a creatine-derived compound: phosphocreatine-Mg-complex acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Improved reperfusion and neuroprotection by creatine in a mouse model of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Neuroprotection does not work!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Prophylactic neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine as an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effects of Creatine in Skeletal Muscle Cells and in Myoblasts Differentiating Under Normal or Oxidatively Stressing Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine phosphate: pharmacological and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Cerebral Synaptic Transmission During Anoxia Is Protected by Creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Scientific basis and practical aspects of creatine supplementation for athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The creatine kinase system and pleiotropic effects of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

The effect of creatine supplementation on myocardial function, mitochondrial respiration and susceptibility to ischaemia/reperfusion injury in sedentary and exercised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Brain water diffusion in normal and creatine-supplemented rats during transient global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Creatine Protects the Central Respiratory Network of Mammals under Anoxic Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Effects of accumulation of phosphocreatine on utilization and restoration of high-energy phosphates during anoxia and recovery in thin hippocampal slices from the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-016-2173-8

10.1007/S00726-016-2173-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26795537%20AND%20SRC:MED&resulttype=core&format=json